ISPOR

Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is the leading global professional society in pharmacoeconomics and outcomes research and advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes).


ISPOR Announces a Brand Refresh for the Society

The New Look was Created to Better Reflect as the Society as theField of Health Economics and Outcomes Research Evolves Lawrenceville, NJ, USA—February 13, 2018—ISPOR, the professional society for health economics and outcomes research, announced today the launch of its new branding. Healthcare is changing at a rapid pace, the […]


Top 10 Trends Driving Healthcare in 2018

ISPOR Announces Influential Topics in Health Economics and Outcomes Research Lawrenceville, NJ, USA—February 6, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the release of its “Top 10 HEOR Trends” list that identifies the most influential topics in the field of health economics and outcomes […]


ISPOR Updates Its Code of Ethics

New Edition Addresses Research Issues in Today’s Digital Health Era Lawrenceville, NJ, USA—January 16, 2018—ISPOR, the professional society for health economics and outcomes research, announced today that it has published an updated code of ethics. The “ISPOR Code of Ethics 2017” was recently published in the December 2017 issue of […]


ISPOR Establishes New Patient Council

Expanding the Society’s Commitment to Patient Engagement in Healthcare Research and Decision Making Lawrenceville, NJ—January 10, 2018—ISPOR, the professional society for health economics and outcomes research, announced the establishment of a new advisory council devoted to patient engagement. The formation of the Patient Council reflects the Society’s long-standing commitment to […]


High-Risk Medical Devices Granted European Licensure Based on Low-Quality Evidence

Value in Health Report Strongly Recommends Enforcing a Requirement of High-Quality Studies for Demonstrating Clinical Efficacy and Safety Lawrenceville, NJ—January 2, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a research report concluding that the quality of […]


ISPOR Undertakes Competencies Initiative for the Field of Health Economics and Outcomes Research

ISPOR HEOR Competencies Framework™Will Focus on Key Competencies Necessary for Professionals in the Field Princeton, NJ—September 19, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced a new initiative today that is focused on the competencies necessary for professionals working in the field of health economics and outcomes research […]


The Voice of the Patient in Latin America

São Paulo. Brazil—17 September 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session, The Voice of the Patient, at its 6th Latin America Conference today focusing on how countries in the region can better incorporate the patient voice in the health care decision-making process. Many […]


Latin America Faces Opportunities and Challenges in the Goal to Achieve Universal Health Care Coverage

São Paulo, Brazil—16 September 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a plenary session at its 6th Latin America Conference today exploring the challenges and opportunities inherent in the move many of the region’s countries are taking toward universal health care coverage. A number of countries in […]


Making Real-World Data Studies More Useful for Health Care Decision Making

Value in Health Publishes Reports From the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making Princeton, NJ—September 15, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of guidance documents that provide new recommendations for developing good procedural practices for conducting studies using […]


ISPOR Latin America Conference to Focus on Improving Health Outcomes Through Stakeholder Engagement

Conference to be Held 15-17 September 2017 in São Paulo, Brazil Princeton, NJ—September 5, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading professional society for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions for its upcoming 6th Latin America Conference scheduled for 15-17 […]


ISPOR/ISPE Announce Plans for “Summit on Real-World Evidence in Health Care Decision Making”

Scheduled for October 20, 2017 in Washington, DC, USA Princeton, NJ—August 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) announced their plans for a 1-day conference focused on real-world evidence. The “ISPOR/ISPE Summit on Real-World Evidence in Health Care Decision Making” […]


ISPOR Leaders Named PharmaVOICE 100 Honorees

Immediate Past-President Professor Lou Garrison and CEO Nancy Berg Recognized as Inspirational Leaders in the Life Sciences Princeton, NJ—August 2, 2017—Two leaders of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) have been named to the renowned list of 2017 PharmaVOICE 100 honorees. Immediate Past-President Lou Garrison, PhD and […]


Randomized Clinical Trials Shown to Accurately Predict Real-World Overall Survival

New Study Compares Clinical Trial Efficacy and Real-World Effectiveness of Therapies for Breast, Colorectal, Lung, Ovarian, and Pancreatic Cancers Princeton, NJ—July 26, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research examining the relationship between the […]


What Is Real-World Data?: A Review of Definitions

New Report Identifies Disparate Opinions on the Meaning of Real World Data Princeton, NJ—July 26, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research that sheds light on health care stakeholders’ perceptions of what qualifies as […]


ISPOR Releases Recommendations for Outcome Assessment in Rare Disease Clinical Trials

Task Force Report Seeks to Improve Bringing the Patient Voice Into Rare Disease Clinical Trials Princeton, NJ—July 25, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a new Task Force Report, Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: Report of […]